Cite Share Efficacy, Safety, and Tolerability of Higher Doses Estrogen Therapy in Women With Premature Ovarian Insufficiency (POI)

Condition:   Primary Ovarian Insufficiency Interventions:   Drug: Transdermal estradiol gel 0.1% 1.5mg/ day;   Drug: Transdermal estradiol gel 0.1% 2.0mg/ day Sponsor:   Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare Active, not recruiting

Source: ClinicalTrials.gov - February 21, 2023 Category: Research Source Type: clinical trials